SCHEMBL25274640

SCHEMBL25274640

O=C(O)N1CCC2(CC1)CN(c1ncnc3ccc(Br)c(F)c13)C2

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 2/20 0.36
▸ HSD17B10 Q99714 11/20 0.35
▸ ALDH1A1 P00352 10/20 0.35
▸ CYP3A4 P08684 9/20 0.35
▸ HPGD P15428 6/20 0.35
▸ TSHR P16473 5/20 0.35
▸ CYP2C19 P33261 6/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CYP2C9 P11712 6/20 0.35
▸ USP2 O75604 6/20 0.35
▸ CYP1A2 P05177 4/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ CYP2D6 P10635 5/20 0.34
▸ HIF1A Q16665 2/20 0.34
▸ MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25422458 0.86 ALDH1A1 (0.35) HSD17B10ALDH1A1CYP3A4HPGDTSHR
SCHEMBL31579068 0.86 MAP4K4 (0.43) HSD17B10ALDH1A1CYP3A4CYP2C19USP2
SCHEMBL25423715 0.85 MEN1 (0.38) HSD17B10ALDH1A1CYP3A4HPGDTSHR
SCHEMBL30406184 0.82 OPRD1 (0.38) HSD17B10ALDH1A1CYP3A4TSHRSMN1; SMN2
SCHEMBL25724531 0.81 AKT1 (0.41) AKT1HSD17B10ALDH1A1CYP3A4HPGD
SCHEMBL25281197 0.78 HTT (0.53) AKT1ALDH1A1HPGDMAPK1USP2
SCHEMBL30406387 0.78 HTT (0.53) AKT1ALDH1A1HPGDMAPK1USP2
SCHEMBL31578990 0.75 MAP4K4 (0.42) HSD17B10ALDH1A1CYP3A4CYP2C19USP2
SCHEMBL25272457 0.75 AKT1 (0.49) AKT1HSD17B10ALDH1A1CYP3A4HPGD
SCHEMBL25724551 0.74 MAP4K4 (0.41) HSD17B10ALDH1A1CYP3A4CYP2C19USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023107696-A2 INHIBITORS OF MENIN-MLL INTERACTION BALA THERAPEUTICS, INC. (US) 2023-06-15 — — WO disclosed
Send feedback